|Articles|September 1, 2012
- Pharmaceutical Executive-09-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2012
Busting the Tape
Advertisement
Articles in this issue
almost 14 years ago
Pharm Exec's 11th Annual Industry Auditalmost 14 years ago
Patients Wade Into the Pricing Debatealmost 14 years ago
The Endless Treadmill of End-of-Life Carealmost 14 years ago
The Power of Patient Feedbackalmost 14 years ago
The Payer C Change: From Customers to Competitorsalmost 14 years ago
The Margin Callalmost 14 years ago
Open Innovation in Pharma: Defining the DialogueAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5